<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>28(9)</volume><submitter>Kojima R</submitter><funding>Mitsubishi Foundation</funding><funding>Japan Foundation of Applied Enzymology</funding><funding>Public Interest Incorporated Foundation Lotte Foundation</funding><funding>The Takeda Foundation</funding><funding>Sapporo Bioscience Foundation</funding><funding>Uehara Memorial Foundation</funding><funding>Government of Japan Ministry of Health Labour and Welfare</funding><funding>Japan Foundation for Aging and Health</funding><funding>Japan Society for the Promotion of Science</funding><pubmed_abstract>&lt;i>trans-&lt;/i>Fatty acids (TFAs) have been associated with various inflammatory diseases, including atherosclerosis and metabolic syndrome, such as metabolic dysfunction-associated steatotic liver disease (MASLD)/metabolic dysfunction-associated steatohepatitis (MASH). However, the underlying mechanism remains unclear. Here, we show that in response to DNA damage, elaidic acid (EA), a most common TFA, amplifies interleukin-1 receptor (IL-1R) signaling, leading to the promotion of cellular senescence and senescence-associated secretory phenotype (SASP). Upon DNA damage, EA enhanced senescence-associated β-galactosidase activity and expressions of IL-1α/6/8 through the IL-1R-transforming growth factor-β-activated kinase 1 (TAK1)-nuclear factor (NF)-κB axis in a manner dependent on mammalian t</pubmed_abstract><journal>iScience</journal><pagination>113305</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12396248</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Elaidic acid drives cellular senescence and inflammation via lipid raft-mediated IL-1R signaling.</pubmed_title><pmcid>PMC12396248</pmcid><pubmed_authors>Noguchi T</pubmed_authors><pubmed_authors>Kojima R</pubmed_authors><pubmed_authors>Sato E</pubmed_authors><pubmed_authors>Ashida R</pubmed_authors><pubmed_authors>Matsuzawa A</pubmed_authors><pubmed_authors>Yokoyama K</pubmed_authors><pubmed_authors>Watanabe A</pubmed_authors><pubmed_authors>Matsui R</pubmed_authors><pubmed_authors>Hirata Y</pubmed_authors><pubmed_authors>Takita R</pubmed_authors><pubmed_authors>Abe T</pubmed_authors><pubmed_authors>Takahashi M</pubmed_authors><pubmed_authors>Hama K</pubmed_authors></additional><is_claimable>false</is_claimable><name>Elaidic acid drives cellular senescence and inflammation via lipid raft-mediated IL-1R signaling.</name><description>&lt;i>trans-&lt;/i>Fatty acids (TFAs) have been associated with various inflammatory diseases, including atherosclerosis and metabolic syndrome, such as metabolic dysfunction-associated steatotic liver disease (MASLD)/metabolic dysfunction-associated steatohepatitis (MASH). However, the underlying mechanism remains unclear. Here, we show that in response to DNA damage, elaidic acid (EA), a most common TFA, amplifies interleukin-1 receptor (IL-1R) signaling, leading to the promotion of cellular senescence and senescence-associated secretory phenotype (SASP). Upon DNA damage, EA enhanced senescence-associated β-galactosidase activity and expressions of IL-1α/6/8 through the IL-1R-transforming growth factor-β-activated kinase 1 (TAK1)-nuclear factor (NF)-κB axis in a manner dependent on mammalian t</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Sep</publication><modification>2026-05-29T17:19:38.079Z</modification><creation>2026-04-08T05:29:33.099Z</creation></dates><accession>S-EPMC12396248</accession><cross_references><pubmed>40894877</pubmed><doi>10.1016/j.isci.2025.113305</doi></cross_references></HashMap>